CARNEXIV Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Carnexiv, and what generic alternatives are available?
Carnexiv is a drug marketed by Lundbeck Pharms Llc and is included in one NDA. There are seven patents protecting this drug.
This drug has seventy-seven patent family members in twenty-one countries.
The generic ingredient in CARNEXIV is carbamazepine. There are twenty-seven drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the carbamazepine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Carnexiv
A generic version of CARNEXIV was approved as carbamazepine by TARO on October 3rd, 1996.
Summary for CARNEXIV
International Patents: | 77 |
US Patents: | 7 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 163 |
Patent Applications: | 4,235 |
Formulation / Manufacturing: | see details |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for CARNEXIV |
What excipients (inactive ingredients) are in CARNEXIV? | CARNEXIV excipients list |
DailyMed Link: | CARNEXIV at DailyMed |
US Patents and Regulatory Information for CARNEXIV
CARNEXIV is protected by nine US patents.
Patents protecting CARNEXIV
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Sulfoalkyl ether cyclodextrin compositions
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Sulfoalkyl ether cyclodextrin compositions
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Alkylated cyclodextrin compositions and processes for preparing and using the same
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Parenteral carbamazepine formulation
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: REPLACEMENT THERAPY FOR ORAL CARBAMAZEPINE IN ADULTS WITH PARTIAL SEIZURES WITH COMPLEX SYMPTOMATOLOGY
Parenteral carbamazepine formulation
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: REPLACEMENT THERAPY FOR ORAL CARBAMAZEPINE IN ADULTS WITH GENERALIZED TONIC-CLONIC SEIZURES
Parenteral carbamazepine formulation
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: REPLACEMENT THERAPY FOR ORAL CARBAMAZEPINE IN ADULTS WITH MIXED SEIZURE PATTERNS THAT INCLUDE PARTIAL SEIZURES WITH COMPLEX SYMPTOMATOLOGY, GENERALIZED TONIC-CLONIC SEIZURES, OR OTHER PARTIAL OR GENERALIZED SEIZURES
Sulfoalkyl ether cyclodextrin compositions
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Parenteral carbamazepine formulation
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lundbeck Pharms Llc | CARNEXIV | carbamazepine | SOLUTION;INTRAVENOUS | 206030-001 | Oct 7, 2016 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Lundbeck Pharms Llc | CARNEXIV | carbamazepine | SOLUTION;INTRAVENOUS | 206030-001 | Oct 7, 2016 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Lundbeck Pharms Llc | CARNEXIV | carbamazepine | SOLUTION;INTRAVENOUS | 206030-001 | Oct 7, 2016 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Lundbeck Pharms Llc | CARNEXIV | carbamazepine | SOLUTION;INTRAVENOUS | 206030-001 | Oct 7, 2016 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Lundbeck Pharms Llc | CARNEXIV | carbamazepine | SOLUTION;INTRAVENOUS | 206030-001 | Oct 7, 2016 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Lundbeck Pharms Llc | CARNEXIV | carbamazepine | SOLUTION;INTRAVENOUS | 206030-001 | Oct 7, 2016 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for CARNEXIV
See the table below for patents covering CARNEXIV around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
China | 110066351 | 烷基化环糊精组合物及其制备和使用方法 (Alkylated cyclodextrin compositions and processes for preparing and using the same) | ⤷ Try a Trial |
Japan | 6444548 | ⤷ Try a Trial | |
Israel | 208956 | תכשירי סולפואלקיל אתר ציקלודקסטרין (Sulfoalkyl ether cyclodextrin compositions) | ⤷ Try a Trial |
Japan | 2013040195 | NEW PARENTERAL CARBAMAZEPINE FORMULATION | ⤷ Try a Trial |
South Korea | 101633479 | ⤷ Try a Trial | |
Japan | 2018052991 | スルホアルキルエーテルシクロデキストリン組成物 (SULFOALKYL ETHER CYCLODEXTRIN COMPOSITIONS) | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |